Regeneratie versus kanker: hoe dragen stamcel potentie en de interactie met de stamcel niche bij tot het omzeilen van het kanker proces?
Regeneratie versus kanker: hoe dragen stamcel potentie, differentiatie en upstream ROS signaling bij tot het ontwijken van het kanker proces?
Co-evolutie van epitheel bij colorectale kanker: uitgebreide karakterisering van progressie-geassocieerde tumorheterogeniteit in de colorectale kanker
Metabole herprogrammering in kanker: een therapie specifiek gericht op serine/glycine synthese-afhankelijke kankers
Design of Clinical Decision Support Systems for Cancer Based upon Clinical and Molecular Data (Ontwerpen van klinische besluitvormingssystemen voor kanker op basis van klinische en moleculaire gegevens)
Mass spectrometer equipped with module for LC ionization source, possibility to work in both positive and negative ionization mode (LCI)
Imaging the invisible in preclinical models using magnetic particle imaging (MPI Magnetic Particle Imaging)
A multimodal non-linear optical platform for 2l3-photon excitation and 2ndl3rd harmonic imaging deep inside living tissues and animals (Multimodal NLO imaging platform)
Additional file 4: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Additional file 6: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Additional file 11: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Additional file 5: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Additional file 9: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families